Trial Profile
Evaluation of Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Amlodipine; Perindopril
- Indications Hypertension; Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- Acronyms NF-NAFLD
- 14 Aug 2014 New trial record